Mumbai: Aurobindo Pharma Ltd has been granted permission by the US Food and Drug Administration for manufacturing and marketing generic Claforan or cefotaxime sodium injections, according to information available on the regulator’s website. The approval is for marketing the drug in 10 mg vials on a prescription basis.
The US regulator also approved Cipla Ltd’s generic version of Kaletra tablets. The drug falls in the anti-retroviral segment and is prescribed for the treatment of HIV/AIDS.